As of 2026-03-10, the Relative Valuation of Organogenesis Holdings Inc (ORGO) is 4.70 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.76 USD, the upside of Organogenesis Holdings Inc based on Relative Valuation is 70.2%.
The range of the Relative Valuation is 2.82 - 6.33 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 16.8x | 11.8x |
| Forward P/E multiples | 18.1x - 24.1x | 22.8x |
| Fair Price | 2.82 - 6.33 | 4.70 |
| Upside | 2.3% - 129.4% | 70.2% |
| Date | P/E |
| 2026-03-06 | 9.56 |
| 2026-03-05 | 9.94 |
| 2026-03-04 | 9.84 |
| 2026-03-03 | 9.84 |
| 2026-03-02 | 10.28 |
| 2026-02-27 | 11.00 |
| 2026-02-26 | 12.68 |
| 2026-02-25 | 14.09 |
| 2026-02-24 | 13.81 |
| 2026-02-23 | 13.43 |
| 2026-02-20 | 13.67 |
| 2026-02-19 | 13.64 |
| 2026-02-18 | 13.16 |
| 2026-02-17 | 12.82 |
| 2026-02-13 | 12.78 |
| 2026-02-12 | 12.82 |
| 2026-02-11 | 12.89 |
| 2026-02-10 | 13.16 |
| 2026-02-09 | 13.13 |
| 2026-02-06 | 12.92 |
| 2026-02-05 | 12.71 |
| 2026-02-04 | 13.37 |
| 2026-02-03 | 13.88 |
| 2026-02-02 | 14.50 |
| 2026-01-30 | 13.71 |
| 2026-01-29 | 13.74 |
| 2026-01-28 | 13.33 |
| 2026-01-27 | 13.67 |
| 2026-01-26 | 13.54 |
| 2026-01-23 | 13.43 |
| 2026-01-22 | 13.71 |
| 2026-01-21 | 13.16 |
| 2026-01-20 | 12.71 |
| 2026-01-16 | 12.99 |
| 2026-01-15 | 13.61 |
| 2026-01-14 | 13.26 |
| 2026-01-13 | 13.98 |
| 2026-01-12 | 14.50 |
| 2026-01-09 | 14.43 |
| 2026-01-08 | 14.43 |
| 2026-01-07 | 14.74 |
| 2026-01-06 | 14.94 |
| 2026-01-05 | 15.11 |
| 2026-01-02 | 15.88 |
| 2025-12-31 | 17.75 |
| 2025-12-30 | 17.75 |
| 2025-12-29 | 17.85 |
| 2025-12-26 | 18.08 |
| 2025-12-24 | 20.12 |
| 2025-12-23 | 19.71 |